Rchr
J-GLOBAL ID:201801021380035354   Update date: Jan. 30, 2024

Ijichi Hideaki

Ijichi Hideaki
Research field  (1): Gastroenterology
Research theme for competitive and other funds  (29):
  • 2021 - 2024 Precision medicine using patient-derived organoid of pancreatic cancer
  • 2021 - 2024 腸内細菌叢による免疫・神経シグナルを介した膵臓癌進展機序の解明
  • 2021 - 2024 Role of BMP signaling in tumor progression in pancreatic cancer using genetically engineered mouse model
  • 2020 - 2023 膵発癌モデルを用いた微小環境の新規標的制御による膵癌制御法の開発
  • 2020 - 2023 膵発癌モデルを用いたVCAM-1阻害による膵癌の全身病態制御機序の解明
Show all
Papers (160):
  • Tomoya Kuramochi, Makoto Sano, Ichie Kajiwara, Yukino Oshima, Tomoaki Itaya, Jinsuk Kim, Yoshimi Ichimaru, Osamu Kitajima, Atsushi Masamune, Hideaki Ijichi, et al. Effects of tramadol via a μ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. Regional Anesthesia & Pain Medicine. 2023. rapm-2023
  • Tomoharu Yamada, Ryosuke Tateishi, Miwako Iwai, Minoru Tanaka, Hideaki Ijichi, Makoto Sano, Kazuhiko Koike, Tomoki Todo. Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors. Molecular therapy oncolytics. 2023. 28. 31-43
  • Takahiro Seimiya, Tatsunori Suzuki, Takuma Iwata, Takahiro Kishikawa, Kazuma Sekiba, Chikako Shibata, Kazunaga Ishigaki, Hiroaki Fujiwara, Hiroki Oyama, Sachiko Kanai, et al. Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancer. iScience. 2023. 26. 2. 106021-106021
  • Tsuyoshi Hamada, Hiroki Oyama, Yousuke Nakai, Shuichi Tange, Junichi Arita, Ryunosuke Hakuta, Hideaki Ijichi, Kazunaga Ishigaki, Sachiko Kanai, Yoshikuni Kawaguchi, et al. Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2023. 21. 7. 1792-1801
  • Tomoaki Itaya, Makoto Sano, Ichie Kajiwara, Yukino Oshima, Tomoya Kuramochi, Jinsuk Kim, Yoshimi Ichimaru, Osamu Kitajima, Atsushi Masamune, Hideaki Ijichi, et al. Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. Pain. 2022. Publish Ahead of Print. 7. 1545-1554
more...
MISC (99):
more...
Professional career (1):
  • MD, PhD (The University of Tokyo)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page